OcuForce
OcuForce, licence 80112240: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80112240
- Status
- Active licence
- Licence date
- 19 August 2021
- Revision date
- 20 October 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 10.0 mg | 20,000 µg |
| Riboflavine Source : Riboflavin 5'-phosphate de sodium | 10.0 mg | 20,000 µg |
| Acide 2-aminoéthanesulfonique Source : Taurine | 100.0 mg | Not calculated |
| Sélénium Source : Glycinate de sélénium | 25.0 mcg | 50 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5.0 mg | 10,000 µg |
| Zinc Source : Diglycinate de zinc | 7.5 mg | 15,000 µg |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 100.0 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 50.0 mg | 100,000 µg |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 5.0 mg | Not calculated |
Non-medicinal ingredients
Huile de tournesol, Tocophérols, Cellulose, Palmitate d'ascorbyle, Hypromellose, Amidon alimentaire, modifié, Phosphate dicalcique, Stéarate de magnésium, Sucre de canne, Silicon dioxide
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain eyesight and in the development and maintenance of night vision. Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Source of/Provides antioxidants for the maintenance of eye health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80112240
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.